{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:33:53Z","timestamp":1792506833729,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40266-024-01137-6","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T20:03:04Z","timestamp":1722715384000},"page":"713-724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Still\u2019s Disease Onset in Older Adults: Clinical Features, Diagnosis, and Management"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0742-831X","authenticated-orcid":false,"given":"Yoshifumi","family":"Tada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Shirahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"key":"1137_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"EG Bywaters","year":"1971","unstructured":"Bywaters EG. Still\u2019s disease in the adult. Ann Rheum Dis. 1971;30:121\u201333.","journal-title":"Ann Rheum Dis"},{"key":"1137_CR2","first-page":"1139","volume":"14","author":"A Ohta","year":"1987","unstructured":"Ohta A, Yamaguchi M, Kaneoka H, Nagayoshi T, Hiida M. Adult Still\u2019s disease: review of 228 cases from the literature. J Rheumatol. 1987;14:1139\u201346.","journal-title":"J Rheumatol"},{"key":"1137_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","volume":"93","author":"R Giacomelli","year":"2018","unstructured":"Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still\u2019s disease. J Autoimmun. 2018;93:24\u201336. https:\/\/doi.org\/10.1016\/j.jaut.2018.07.018.","journal-title":"J Autoimmun"},{"key":"1137_CR4","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","volume":"13","author":"M Gerfaud-Valentin","year":"2014","unstructured":"Gerfaud-Valentin M, Jamilloux Y, Iwaz J, S\u00e8ve P. Adult-onset Still\u2019s disease. Autoimmun Rev. 2014;13:708\u201322. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.058.","journal-title":"Autoimmun Rev"},{"key":"1137_CR5","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s10067-016-3308-8","volume":"35","author":"P Sfriso","year":"2016","unstructured":"Sfriso P, Priori R, Valesini G, Rossi S, Montecucco CM, D\u2019Ascanio A, et al. Adult-onset Still\u2019s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients. Clin Rheumatol. 2016;35:1683\u20139. https:\/\/doi.org\/10.1007\/s10067-016-3308-8.","journal-title":"Clin Rheumatol"},{"key":"1137_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","volume":"33","author":"P Efthimiou","year":"2014","unstructured":"Efthimiou P, Kadavath S, Mehta B. Life-threatening complications of adult-onset Still\u2019s disease. Clin Rheumatol. 2014;33:305\u201314. https:\/\/doi.org\/10.1007\/s10067-014-2487-4.","journal-title":"Clin Rheumatol"},{"key":"1137_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.berh.2014.03.002","volume":"28","author":"GS Schulert","year":"2014","unstructured":"Schulert GS, Grom AA. Macrophage activation syndrome and cytokine-directed therapies. Best Prac Clin Rheumatol. 2014;28:277\u201392. https:\/\/doi.org\/10.1016\/j.berh.2014.03.002.","journal-title":"Best Prac Clin Rheumatol."},{"key":"1137_CR8","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s10067-017-3830-3","volume":"36","author":"P Ruscitti","year":"2017","unstructured":"Ruscitti P, Rago C, Breda L, Cipriani P, Liakouli V, Berardicurti O, et al. Macrophage activation syndrome in Still\u2019s disease: analysis of clinical characteristics and survival in paediatric and adult patients. Clin Rheumatol. 2017;36:2839\u201345. https:\/\/doi.org\/10.1007\/s10067-017-3830-3.","journal-title":"Clin Rheumatol"},{"issue":"Suppl 132","key":"1137_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.55563\/clinexprheumatol\/lp2u7g","volume":"39","author":"Q Gao","year":"2021","unstructured":"Gao Q, Yuan Y, Wang Y, Jiang J, Ye Z, Liu T, et al. Clinical characteristics of macrophage activation syndrome in adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2021;39(Suppl 132):59\u201366. https:\/\/doi.org\/10.55563\/clinexprheumatol\/lp2u7g.","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 121","key":"1137_CR10","first-page":"83","volume":"37","author":"X-P Yang","year":"2019","unstructured":"Yang X-P, Wang M, Li T-F, Li W, Zhang L, Liu S-Y. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2019;37(Suppl 121):83\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"1137_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","volume":"61","author":"Y Jamilloux","year":"2015","unstructured":"Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, S\u00e8ve P. Pathogenesis of adult-onset Still\u2019s disease: new insights from the juvenile counterpart. Immunol Res. 2015;61:53\u201362. https:\/\/doi.org\/10.1007\/s12026-014-8561-9.","journal-title":"Immunol Res"},{"key":"1137_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist E, Mitrovic S, Fautrel B. Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol. 2018;14:603\u201318. https:\/\/doi.org\/10.1038\/s41584-018-0081-x.","journal-title":"Nat Rev Rheumatol"},{"key":"1137_CR13","first-page":"427","volume":"20","author":"F Luthi","year":"2002","unstructured":"Luthi F, Zufferey P, Hofer MF, So AK. \u201cAdolescent-onset Still\u2019s disease\u201d: characteristics and outcome in comparison with adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2002;20:427\u201330.","journal-title":"Clin Exp Rheumatol"},{"key":"1137_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10067-005-0138-5","volume":"25","author":"S Pay","year":"2006","unstructured":"Pay S, Turkcapar N, Kalyoncu M, Simsek I, Beyan E, Ertenli I, et al. A multicenter study of patients with adult-onset Still\u2019s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol. 2006;25:639\u201344. https:\/\/doi.org\/10.1007\/s10067-005-0138-5.","journal-title":"Clin Rheumatol"},{"key":"1137_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","volume":"169","author":"N Inoue","year":"2016","unstructured":"Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine pofile in adult-onset Still\u2019s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol. 2016;169:8\u201313. https:\/\/doi.org\/10.1016\/j.clim.2016.05.010.","journal-title":"Clin Immunol"},{"key":"1137_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s100670050030","volume":"19","author":"SJ Lin","year":"2000","unstructured":"Lin SJ, Chao HC, Yan DC. Different articular outcomes of Still\u2019s disease in Chinese children and adults. Clin Rheumatol. 2000;19:127\u201330. https:\/\/doi.org\/10.1007\/s100670050030.","journal-title":"Clin Rheumatol"},{"key":"1137_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003578","volume":"9","author":"A Vitale","year":"2023","unstructured":"Vitale A, Caggiano V, Lopalco G, Mayrink Giardini HA, Ciccia F, et al. Still\u2019s disease continuum from childhood to elderly: data from the international AIDA network Still\u2019s registry. RMD Open. 2023;9: e003578. https:\/\/doi.org\/10.1136\/rmdopen-2023-003578.","journal-title":"RMD Open"},{"key":"1137_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.semarthrit.2010.12.006","volume":"41","author":"M Colina","year":"2011","unstructured":"Colina M, Zucchini W, Ciancio G, Orzincolo C, Trotta F, Govoni M. The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum. 2011;41:279\u201385. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.12.006.","journal-title":"Semin Arthritis Rheum"},{"key":"1137_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, D\u00e9cary F, Slusinsky-Sternbach M, et al. Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991;70:118\u201336.","journal-title":"Medicine (Baltimore)"},{"key":"1137_CR20","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1001\/jama.1983.03330390066034","volume":"249","author":"LA Steffe","year":"1983","unstructured":"Steffe LA, Cooke CL. Still\u2019s disease in a 70-year-old woman. JAMA. 1983;249:2062\u20133.","journal-title":"JAMA"},{"key":"1137_CR21","first-page":"791","volume":"12","author":"JM Woulters","year":"1985","unstructured":"Woulters JM, van Rijswijk MH, van de Putte LB. Adult onset Still\u2019s disease in the elderly: a report of two cases. J Rheumatol. 1985;12:791\u20133.","journal-title":"J Rheumatol"},{"key":"1137_CR22","first-page":"1608","volume":"20","author":"J Uson","year":"1993","unstructured":"Uson J, Pe\u00f1a JM, del Arco A, Barbado FJ, Vazquez JJ. Still\u2019s disease in a 72-year-old man. J Rheumatol. 1993;20:1608\u20139.","journal-title":"J Rheumatol"},{"key":"1137_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3109\/14397595.2014.974881","volume":"25","author":"YF Asanuma","year":"2015","unstructured":"Asanuma YF, Mimura T, Tsuboi H, Noma H, Miyoshi F, Yamamoto K, et al. Nationwide epidemiological survey of 169 patients with adult Still\u2019s disease in Japan. Mod Rheumatol. 2015;25:393\u2013400. https:\/\/doi.org\/10.3109\/14397595.2014.974881.","journal-title":"Mod Rheumatol"},{"key":"1137_CR24","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1007\/s00296-016-3546-8","volume":"36","author":"N Sakata","year":"2016","unstructured":"Sakata N, Shimizu S, Hirano F, Fushimi K. Epidemiological study of adult-onset Still\u2019s disease using a Japanese administrative database. Rheumatol Int. 2016;36:1399\u2013405. https:\/\/doi.org\/10.1007\/s00296-016-3546-8.","journal-title":"Rheumatol Int"},{"key":"1137_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/pmj.78.916.97","volume":"78","author":"GS Stoica","year":"2002","unstructured":"Stoica GS, Cohen RI, Rossoff LJ. Adult Still\u2019s disease and respiratory failure in a 74 year old woman. Postgrad Med J. 2002;78:97\u20138. https:\/\/doi.org\/10.1136\/pmj.78.916.97.","journal-title":"Postgrad Med J"},{"key":"1137_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/ageing\/afl128","volume":"36","author":"M Kurasawa","year":"2007","unstructured":"Kurasawa M, Kotani K, Kurasawa G, Shida K, Yamada S, Tago T. Adult-onset Still\u2019s disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy. Age Ageing. 2007;36:104\u20136. https:\/\/doi.org\/10.1093\/ageing\/afl128.","journal-title":"Age Ageing"},{"key":"1137_CR27","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1378\/chest.09-0722","volume":"136","author":"A Limsukon","year":"2009","unstructured":"Limsukon A, Jones HD, Feinstein J. A 60-year-old Japanese man with fevers, myalgias, pharyngitis, and right knee pain. Chest. 2009;136:1428\u201331. https:\/\/doi.org\/10.1378\/chest.09-0722.","journal-title":"Chest"},{"key":"1137_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s10067-010-1418-2","volume":"29","author":"K Sumida","year":"2010","unstructured":"Sumida K, Ubara Y, Hoshino J, Suwabe T, Hiramatsu R, Hasegawa E, et al. Etanercept-refractory adult-onset Still\u2019s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab. Clin Rheumatol. 2010;29:1191\u20134. https:\/\/doi.org\/10.1007\/s10067-010-1418-2.","journal-title":"Clin Rheumatol"},{"key":"1137_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-235786","volume":"13","author":"R Kato","year":"2020","unstructured":"Kato R, Ikeuchi T, Tomita K, Yamasaki A. Adult-onset Still\u2019s disease with concurrent thrombotic thrombocytopenic purpura: case report and literature review. BMJ Case Rep. 2020;13: e235786. https:\/\/doi.org\/10.1136\/bcr-2020-235786.","journal-title":"BMJ Case Rep"},{"key":"1137_CR30","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/RHU.0000000000000812","volume":"26","author":"M Bhamra","year":"2020","unstructured":"Bhamra M, Amarnani A, Ozeri D. Unprovoked pulmonary embolism identified on initial presentation of adult-onset Still\u2019s disease in an elderly patient with no malignancy. J Clin Rheumatol. 2020;26:e40\u20132. https:\/\/doi.org\/10.1097\/RHU.0000000000000812.","journal-title":"J Clin Rheumatol"},{"key":"1137_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2169\/internalmedicine.3727-19","volume":"59","author":"T Suda","year":"2020","unstructured":"Suda T, Zoshima T, Takeji A, Suzuki Y, Mizushima I, Yamada K, et al. Elderly-onset Still\u2019s disease complicated by macrophage activation syndrome: a case report and review of the literature. Intern Med. 2020;59:721\u20138. https:\/\/doi.org\/10.2169\/internalmedicine.3727-19.","journal-title":"Intern Med"},{"key":"1137_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41927-021-00183-6","volume":"5","author":"A Mollaeian","year":"2021","unstructured":"Mollaeian A, Chen J, Chan NN, Nizialek GA, Haas CJ. Adult onset Still\u2019s disease in the elderly: a case-based literature review. BMC Rheumatol. 2021;5:12. https:\/\/doi.org\/10.1186\/s41927-021-00183-6.","journal-title":"BMC Rheumatol."},{"key":"1137_CR33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.5114\/reum.2021.107323","volume":"59","author":"A Mzabi","year":"2021","unstructured":"Mzabi A, Fakhfakh R, Thabet M, Hassine IB, Anoun J, Karmani M, et al. Elderly-onset adult Still\u2019s disease. Rheumatologia. 2021;59:188\u201396. https:\/\/doi.org\/10.5114\/reum.2021.107323.","journal-title":"Rheumatologia"},{"key":"1137_CR34","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1080\/14397595.2020.1829340","volume":"31","author":"A Maruyama","year":"2021","unstructured":"Maruyama A, Kokuzawa A, Yamauchi Y, Kirino Y, Nagai H, Inoue Y, et al. Clinical features of elderly-onset adult-onset Still\u2019s disease. Mod Rheumatol. 2021;31:862\u20138. https:\/\/doi.org\/10.1080\/14397595.2020.1829340.","journal-title":"Mod Rheumatol"},{"key":"1137_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1620\/tjem.255.195","volume":"255","author":"E Suzuki","year":"2021","unstructured":"Suzuki E, Temmoku J, Fujita Y, Yashiro-Furuya M, Asano T, Kanno T, et al. Clinical characteristics of Japanese patients with elderly-onset Adult-onset Still\u2019s disease. Tohoku J Exp Med. 2021;255:195\u2013202. https:\/\/doi.org\/10.1620\/tjem.255.195.","journal-title":"Tohoku J Exp Med"},{"key":"1137_CR36","doi-asserted-by":"publisher","first-page":"6768","DOI":"10.1038\/s41598-022-10932-3","volume":"12","author":"D Kishida","year":"2022","unstructured":"Kishida D, Ichikawa T, Takamatsu R, Nomura S, Matsuda M, Ishii W, et al. Clinical characteristics and treatment of elderly onset adult-onset Still\u2019s disease. Sci Rep. 2022;12:6768. https:\/\/doi.org\/10.1038\/s41598-022-10932-3.","journal-title":"Sci Rep"},{"key":"1137_CR37","doi-asserted-by":"publisher","first-page":"21334","DOI":"10.1038\/s41598-022-25514-6","volume":"12","author":"M Yagishita","year":"2022","unstructured":"Yagishita M, Tsuboi H, Kuroda Y, Sawabe T, Kawashima A, Kawashima F, et al. Clinical features and serum cytokine profiles of elderly-onset adult-onset Still\u2019s disease. Sci Rep. 2022;12:21334. https:\/\/doi.org\/10.1038\/s41598-022-25514-6.","journal-title":"Sci Rep"},{"key":"1137_CR38","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.55563\/clinexprheumatol\/0215kv","volume":"40","author":"I Di Cola","year":"2022","unstructured":"Di Cola I, Di Muzio C, Conforti A, Iacono D, Pantano I, Rozza G, et al. Adult-onset Still\u2019s disease with elder onset: results from a multicentre study. Clin Exp Rheumatol. 2022;40:1517\u201325. https:\/\/doi.org\/10.55563\/clinexprheumatol\/0215kv.","journal-title":"Clin Exp Rheumatol"},{"key":"1137_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2023.100196","volume":"6","author":"S Li","year":"2023","unstructured":"Li S, Ying S, Bai J, Wang Y, Yang C, Sun Q, et al. Clinical characteristics and outcome of elderly onset adult-onset Still\u2019s disease: a 10-year retrospective study. J Transl Autoimmun. 2023;6: 100196. https:\/\/doi.org\/10.1016\/j.jtauto.2023.100196.","journal-title":"J Transl Autoimmun."},{"key":"1137_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003578","volume":"9","author":"A Vitale","year":"2023","unstructured":"Vitale A, Caggiano V, Lopalco G, Giardini HAM, Ciccila F, Almaghlouth IA, et al. Still\u2019s disease continuum from childhood to elderly: data from the international AIDA network Still\u2019s disease registry. RMD Open. 2023;9: e003578. https:\/\/doi.org\/10.1136\/rmdopen-2023-003578.","journal-title":"RMD Open"},{"key":"1137_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006318","volume":"96","author":"FJ Narvaez Garcia","year":"2017","unstructured":"Narvaez Garcia FJ, Pascual M, de Recalde ML, Juarez P, Morales-Ivorra I, Notario J, et al. Adult-onset Still\u2019s disease with atypical cutaneous manifestations. Medicine (Baltimore). 2017;96: e6318. https:\/\/doi.org\/10.1097\/MD.0000000000006318.","journal-title":"Medicine (Baltimore)"},{"key":"1137_CR42","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000518321","volume":"183","author":"X Huang","year":"2022","unstructured":"Huang X, Jia N, Xiao F, Sun C, Zhu J, Lai J, et al. Differences in the clinical manifestations and mortality on systemic lupus erythematosus onset in children and adults: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2022;183:116\u201326. https:\/\/doi.org\/10.1159\/000518321.","journal-title":"Int Arch Allergy Immunol"},{"key":"1137_CR43","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.semarthrit.2018.01.010","volume":"48","author":"JL Medlin","year":"2018","unstructured":"Medlin JL, Hansen KE, McCoy SS, Bartels CM. Pulmonary manifestations in late versus early systemic lupus erythematosus: a systematic review and meta-analysis. Semin arthritis Rheum. 2018;48:198\u2013204. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.01.010.","journal-title":"Semin arthritis Rheum"},{"key":"1137_CR44","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1177\/0961203317699284","volume":"26","author":"MJ Haye Salinas","year":"2017","unstructured":"Haye Salinas MJ, Caeiro F, Saurit V, Alvarellos A, Wojdyla D, Scherbarth HR, et al. Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin America inception cohort (GLADEL). Lupus. 2017;26:1368\u201377. https:\/\/doi.org\/10.1177\/0961203317699284.","journal-title":"Lupus"},{"key":"1137_CR45","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.12659\/ajcr.905684","volume":"18","author":"S Yamashita","year":"2017","unstructured":"Yamashita S, Furukawa NE, Matsunaga T, Hirakawa Y, Tago M, Yamashita S. Extremely high serum ferritin: an instrumental marker of masquerading adult-onset Still\u2019s disease with hemophagocytic syndrome. Am J Case Rep. 2017;18:1296\u2013301. https:\/\/doi.org\/10.12659\/ajcr.905684.","journal-title":"Am J Case Rep."},{"key":"1137_CR46","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19:424\u201330.","journal-title":"J Rheumatol"},{"key":"1137_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/ard.51.5.683","volume":"51","author":"M Schwarz-Eywill","year":"1992","unstructured":"Schwarz-Eywill M, Heilig B, Bauer H, Breitbart A, Pezzutto A. Evaluation of serum ferritin as a marker for adult Still\u2019s disease activity. Ann Rheum Dis. 1992;51:683\u20135. https:\/\/doi.org\/10.1136\/ard.51.5.683.","journal-title":"Ann Rheum Dis"},{"key":"1137_CR48","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.59.5.347","volume":"59","author":"S Vignes","year":"2000","unstructured":"Vignes S, Le Mo\u00ebl G, Gautrel B, Wechsler B, Godeau P, Piette JC. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still\u2019s disease. Ann Rheum Dis. 2000;59:347\u201350. https:\/\/doi.org\/10.1136\/ard.59.5.347.","journal-title":"Ann Rheum Dis"},{"key":"1137_CR49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","volume":"81","author":"B Fautrel","year":"2002","unstructured":"Fautrel B, Zing E, Golmard JL, Le Mo\u00ebl G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81:194\u2013200. https:\/\/doi.org\/10.1097\/00005792-200205000-00003.","journal-title":"Medicine (Baltimore)"},{"key":"1137_CR50","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","volume":"10","author":"E Karakike","year":"2019","unstructured":"Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: a distinct entity leading to early death in Sepsis. Fromt Immunol. 2019;10:55. https:\/\/doi.org\/10.3389\/fimmu.2019.00055.","journal-title":"Fromt Immunol."},{"key":"1137_CR51","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/ard.2008.098335","volume":"68","author":"DY Chen","year":"2009","unstructured":"Chen DY, Chen YM, Ho WL, Chen HH, Shen GH, et al. Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still\u2019s disease. Ann Rheum Dis. 2009;68:1074\u20135. https:\/\/doi.org\/10.1136\/ard.2008.098335.","journal-title":"Ann Rheum Dis"},{"key":"1137_CR52","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.130575","volume":"41","author":"R Priori","year":"2014","unstructured":"Priori R, Colafrancesco S, Alessandri C, Minniti A, Perricone C, Iaiani G, et al. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still\u2019s disease and sepsis. J Rheumatol. 2014;41:1118\u201323. https:\/\/doi.org\/10.3899\/jrheum.130575.","journal-title":"J Rheumatol"},{"key":"1137_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654811","volume":"12","author":"R Tian","year":"2021","unstructured":"Tian R, Chen X, Yang C, Teng J, Qu H, Liu HL. Serum heparin-binding protein as a potential biomarker to distinguish adult-onset Still\u2019s disease from sepsis. Front Immunol. 2021;12: 654811. https:\/\/doi.org\/10.3389\/fimmu.2021.654811.","journal-title":"Front Immunol"},{"key":"1137_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155642","volume":"146","author":"W Zhang","year":"2021","unstructured":"Zhang W, Yang T, Zhang H, Xu Y, Yang Q, Liu Q. Biomarker screening and validation for the differentiation of blood stream infection from adult-onset Still\u2019s disease: a prospective cohort study. Cytokine. 2021;146: 155642. https:\/\/doi.org\/10.1016\/j.cyto.2021.155642.","journal-title":"Cytokine"},{"key":"1137_CR55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00508-020-01668-z","volume":"133","author":"M Zhang","year":"2021","unstructured":"Zhang M, Xie M, Wang Y, Li J, Zhou J. Combination value of biomarkers in discriminating adult onset Still\u2019s disease and sepsis. Wien Klin Wochenschr. 2021;133:118\u201322. https:\/\/doi.org\/10.1007\/s00508-020-01668-z.","journal-title":"Wien Klin Wochenschr"},{"key":"1137_CR56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-020-02200-4","volume":"22","author":"T Koga","year":"2020","unstructured":"Koga T, Sumiyoshi R, Furukawa K, Sato S, Migita K, Shimizu T, et al. Interleukin-18 and fibroblast growth factor-2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still\u2019s disease from sepsis. Arthritis Res Ther. 2020;22:108. https:\/\/doi.org\/10.1186\/s13075-020-02200-4.","journal-title":"Arthritis Res Ther"},{"key":"1137_CR57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13075-023-03207-3","volume":"25","author":"D Zhou","year":"2023","unstructured":"Zhou D, Xie J, Wang J, Zong J, Fang Q, Luo F, et al. Establishment of a differential diagnosis method and an online prediction platform for AOSD and sepsis based on gradient boosting decision trees algorithm. Arthritis Res Ther. 2023;25:220. https:\/\/doi.org\/10.1186\/s13075-023-03207-3.","journal-title":"Arthritis Res Ther"},{"key":"1137_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1752-1947-6-195","volume":"6","author":"EM Manoj","year":"2012","unstructured":"Manoj EM, Srigrishna R, Ragunathan MK. Hepatic tuberculosis presenting with extreme hyperferritinemia masquerading as adult-onset Still\u2019s disease: a case report. J Med Case Rep. 2012;6:195. https:\/\/doi.org\/10.1186\/1752-1947-6-195.","journal-title":"J Med Case Rep"},{"key":"1137_CR59","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000023204","volume":"99","author":"M Song","year":"2020","unstructured":"Song M, Kim SJ, Yoo JY. Corticosteroid-induced exacerbation of cryptic miliary tuberculosis to acute respiratory distress syndrome: a case report. Medicine (Baltimore). 2020;99: e23204. https:\/\/doi.org\/10.1097\/MD.0000000000023204.","journal-title":"Medicine (Baltimore)"},{"key":"1137_CR60","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s10238-022-00903-3","volume":"23","author":"AK Pannu","year":"2023","unstructured":"Pannu AK, Singla V, Suri V, Kumar R, Mathur Y, Mohindra R, et al. Adult-onset Still\u2019s disease and fever of unknown origin in India. Clin Exp Med. 2023;23:1659\u201366. https:\/\/doi.org\/10.1007\/s10238-022-00903-3.","journal-title":"Clin Exp Med"},{"key":"1137_CR61","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s10067-015-2901-6","volume":"34","author":"M-J Dong","year":"2015","unstructured":"Dong M-J, Wang C-Q, Zhao K, Wang G-L, Sun M-L, Liu Z-F, et al. 18F-FDG PET\/CT in patients with adult-onset Still\u2019s disease. Clin Rheumatol. 2015;34:2047\u201356. https:\/\/doi.org\/10.1007\/s10067-015-2901-6.","journal-title":"Clin Rheumatol"},{"key":"1137_CR62","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11926-018-0779-4","volume":"20","author":"E Mabey","year":"2018","unstructured":"Mabey E, Rutherford A, Galloway J. Differentiating disease flare from infection: a common problem in rheumatology. Do 18F-FDG PET\/CT scans and novel biomarkers hold the answer? Curr Rheumatol Rep. 2018;20:70. https:\/\/doi.org\/10.1007\/s11926-018-0779-4.","journal-title":"Curr Rheumatol Rep"},{"key":"1137_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102573","volume":"19","author":"S Colafrancesco","year":"2020","unstructured":"Colafrancesco S, Alessandri C, Conti F, Priori R. COVID-19 gone bad: a new chracter in the spectrum of the hyperferritinemic syndrome. Autoimmun Rev. 2020;19: 102573. https:\/\/doi.org\/10.1016\/j.autrev.2020.102573.","journal-title":"Autoimmun Rev"},{"key":"1137_CR64","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3389\/fimmu.2020.01130","volume":"11","author":"P Ruscitti","year":"2020","unstructured":"Ruscitti P, Berardicurti O, Di Benedetto P, Cipriani P, Iagnocco A, Shoenfeld Y, et al. Severe COVID-19, another piece in the puzzle of the hyperferritinemic syndrome. An immunomodulatory perspective to alleviate the storm. From Immunol. 2020;11:1130. https:\/\/doi.org\/10.3389\/fimmu.2020.01130.","journal-title":"From Immunol."},{"key":"1137_CR65","doi-asserted-by":"publisher","first-page":"631","DOI":"10.55563\/clinexprheumatol\/44kaji","volume":"631","author":"Y Kondo","year":"2021","unstructured":"Kondo Y, Kaneko Y, Takei H, Tamai H, Kabata H, Suhara T, et al. COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still\u2019s disease. Clin Exp Rheumatol. 2021;631:631\u20138. https:\/\/doi.org\/10.55563\/clinexprheumatol\/44kaji.","journal-title":"Clin Exp Rheumatol"},{"key":"1137_CR66","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00296-012-2377-5","volume":"33","author":"M Saghafi","year":"2013","unstructured":"Saghafi M, Sahebari M. Does searching for antineutrophil cytoplasmic antibodies help with the diagnosis of adult-onset Still\u2019s disease? Rheumatol Int. 2013;33:571\u20134. https:\/\/doi.org\/10.1007\/s00296-012-2377-5.","journal-title":"Rheumatol Int"},{"key":"1137_CR67","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/.s10067-020-05041-3","volume":"39","author":"X Zhou","year":"2020","unstructured":"Zhou X, Li Y, Wang Q. FDG PET\/CT used in identifying adult-onset Still\u2019s disease in connective tissue diseases. Clin Rheumatol. 2020;39:2735\u201342. https:\/\/doi.org\/10.1007\/.s10067-020-05041-3.","journal-title":"Clin Rheumatol"},{"key":"1137_CR68","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s13075-014-0423-2","volume":"16","author":"H Yamashita","year":"2014","unstructured":"Yamashita H, Kubota K, Mimori A. Clinical value of whole-body PET\/CT in patients with active rheumatic diseases. Arthritis Res Ther. 2014;16:423. https:\/\/doi.org\/10.1186\/s13075-014-0423-2.","journal-title":"Arthritis Res Ther"},{"key":"1137_CR69","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383:2628\u201338. https:\/\/doi.org\/10.1056\/NEJMoa2026834.","journal-title":"N Engl J Med"},{"key":"1137_CR70","doi-asserted-by":"publisher","unstructured":"Maeda A, Tsuchida N, Uchiyama Y, Horita N, Kobayashi S, Kishimoto M, et al. Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kead425. (Online ahead of print).","DOI":"10.1093\/rheumatology\/kead425"},{"key":"1137_CR71","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.3390\/jcm10235586","volume":"10","author":"M Delplanque","year":"2021","unstructured":"Delplanque M, Aouba A, Hirsch P, Fenaux P, Graveleau J, Malard F, et al. USAID associated with myeloid neoplasm and VEXAS syndrome: two differential diagnoses of suspected adult onset Still\u2019s disease in elderly patients. J Clin Med. 2021;10:5586. https:\/\/doi.org\/10.3390\/jcm10235586.","journal-title":"J Clin Med"},{"key":"1137_CR72","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s10067-018-4178-z","volume":"37","author":"H Li","year":"2018","unstructured":"Li H, Abramova I, Chesoni S, Yao Q. Molecular genetic analysis for periodic fever syndromes: a supplemental role for the diagnosis of adult-onset Still\u2019s disease. Clin Rheumatol. 2018;37:2021\u20136. https:\/\/doi.org\/10.1007\/s10067-018-4178-z.","journal-title":"Clin Rheumatol"},{"key":"1137_CR73","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.semarthrit.2015.10.003","volume":"45","author":"K Hofheinz","year":"2016","unstructured":"Hofheinz K, Schett G, Manger B. Adult onset Still\u2019s disease associated with malignancy\u2014cause or coincidence? Semin Arthritis Rheum. 2016;45:621\u20136. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.10.003.","journal-title":"Semin Arthritis Rheum"},{"key":"1137_CR74","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jaad.2015.04.063","volume":"73","author":"NZ Sun","year":"2015","unstructured":"Sun NZ, Brezinski EA, Berliner J, Haemel A, Connolly K, Gensler L, et al. Updates in adult-onset Still disease: atypical cutaneous manifestations and associations with delayed malignancy. J Am Acad Dermatol. 2015;73:294\u2013303. https:\/\/doi.org\/10.1016\/j.jaad.2015.04.063.","journal-title":"J Am Acad Dermatol"},{"key":"1137_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750114","volume":"12","author":"T Shiga","year":"2021","unstructured":"Shiga T, Nozaki Y, Tomita D, Kishimoto K, Hirooka Y, Kinoshita K, et al. Usefulness of interleukin-18 as a diagnostic biomarker to differentiate adult-onset Still\u2019s disease with\/without macrophage activation syndrome from other secondary hemophagocytic lymphohistiocytosis in adults. Front Immunol. 2021;12: 750114. https:\/\/doi.org\/10.3389\/fimmu.2021.750114. (eCollection 2021).","journal-title":"Front Immunol"},{"key":"1137_CR76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.21037\/qims-22-246","volume":"13","author":"L Wan","year":"2023","unstructured":"Wan L, Gao Y, Yang C, Gu J, Liu T, Hu Q, et al. Differential diagnostic performance of PET\/CT in adult-onset still\u2019s disease and lymphoma: a retrospective pilot study. Quant Imaging Med Surg. 2023;13:27\u201348. https:\/\/doi.org\/10.21037\/qims-22-246.","journal-title":"Quant Imaging Med Surg"},{"key":"1137_CR77","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.semarthrit.2015.11.002","volume":"45","author":"A Lenert","year":"2016","unstructured":"Lenert A, Yao Q. Macrophage activation syndrome complicating adult onset Still\u2019s disease: a single center case series and comparison with literature. Semin Arthritis Rheum. 2016;45:711\u20136. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.11.002.","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 127","key":"1137_CR78","first-page":"11","volume":"38","author":"H Nakamura","year":"2020","unstructured":"Nakamura H, Fujieda Y, Tarumi M, Kitakawa H, Hisada R, Nakagawa I, et al. Calcineurin inhibitors for adult-onset Still\u2019s disease: a multicentre retrospective cohort study. Clin Exp Rheumatol. 2020;38(Suppl 127):11\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"1137_CR79","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fphar.2017.00369","volume":"8","author":"S Colafrancesco","year":"2017","unstructured":"Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, et al. Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset Still\u2019s disease: a multicentre retrospective observational study. Frront Pharmacol. 2017;8:369. https:\/\/doi.org\/10.3389\/fphar.2017.00369.","journal-title":"Frront Pharmacol."},{"key":"1137_CR80","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fphar.2019.00296","volume":"10","author":"A Vitale","year":"2019","unstructured":"Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, et al. Long-term retention rate of Anakinra in adult onset Still\u2019s disease and predictive factors for treatment response. Front Pharmacol. 2019;10:296. https:\/\/doi.org\/10.3389\/fphar.2019.00296.","journal-title":"Front Pharmacol"},{"key":"1137_CR81","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/annrheumdis-2020-217155","volume":"79","author":"C Kedor","year":"2020","unstructured":"Kedor C, Listing J, Zernicke J, Wei\u00df A, Behrens F, Blank N, et al. Canakinumab for the treatment of adult onset still\u2019s disease to achieve reduction of arthritic manifestation (CONSIDER): phase II, randomized, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Ann Rheum Dis. 2020;79:1090\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217155.","journal-title":"Ann Rheum Dis"},{"key":"1137_CR82","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/annrheumdis-2018-213920","volume":"77","author":"Y Kaneko","year":"2018","unstructured":"Kaneko Y, Kameda H, Ikeda K, Ishii T, Murakami K, Takamatsu H, et al. Tocilizumab in patients with adult-onset still\u2019s disease refractory to glucocorticoid treatment: a randomized, double-blind, placebo-controlled phase III trial. Ann Rheum Dis. 2018;77:1720\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213920.","journal-title":"Ann Rheum Dis"},{"key":"1137_CR83","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/14397595.2017.1416924","volume":"28","author":"Y Ma","year":"2018","unstructured":"Ma Y, Wu M, Zhang X, Xia Q, Yang J, Xu S, et al. Efficacy and safety of tocilizymab with inhibition of interleukin-6 in adult-onset Still\u2019s disease: a meta-analysis. Mod Rheumatol. 2018;28:849\u201357. https:\/\/doi.org\/10.1080\/14397595.2017.1416924.","journal-title":"Mod Rheumatol"},{"key":"1137_CR84","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001246","volume":"6","author":"M Kacar","year":"2020","unstructured":"Kacar M, Fitton J, Gough AK, Buch MH, McGonagle DG, Savic S. Mixed results with baricitinib in biological-resistant adult-onset Still\u2019s disease and undifferentiated systemic autoinflammatory disease. BMD Open. 2020;6: e001246. https:\/\/doi.org\/10.1136\/rmdopen-2020-001246.","journal-title":"BMD Open."},{"key":"1137_CR85","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40268-023-00417-7","volume":"23","author":"Z Sun","year":"2023","unstructured":"Sun Z, Li R, Wang Y, Han F, Wei W, Li X. Efficacy of baricitinib in patients with refractory adult-onset Still\u2019s disease. Drugs RD. 2023;23:109\u201320. https:\/\/doi.org\/10.1007\/s40268-023-00417-7.","journal-title":"Drugs RD."},{"key":"1137_CR86","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/14397595.2018.1465633","volume":"28","author":"T Mimura","year":"2018","unstructured":"Mimura T, Kondo Y, Ohta A, Iwamoto M, Ota A, Okamoto N, et al. Evidence-based clinical practice guideline for adult Still\u2019s disease. Mod Rheumatol. 2018;28:736\u201357. https:\/\/doi.org\/10.1080\/14397595.2018.1465633.","journal-title":"Mod Rheumatol"},{"key":"1137_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103400","volume":"22","author":"R Giacomelli","year":"2023","unstructured":"Giacomelli R, Caporali R, Ciccia F, Colafrancesco S, Dagna L, Govoni M, et al. Expert consensus on the treatment of patients with adult-onset still\u2019s disease with the goal of achieving an early and long-term remission. Autoimmun Rev. 2023;22: 103400. https:\/\/doi.org\/10.1016\/j.autrev.2023.103400.","journal-title":"Autoimmun Rev"},{"key":"1137_CR88","doi-asserted-by":"publisher","unstructured":"Leavis HL, van Daele PLA, Mulders-Manders C, Michels R, Rutgers A, Legger E, et al. Management of adult-onset Still\u2019s disease: evidence- and consensus-based recommendations by experts. Rheumatology. 2023. https:\/\/doi.org\/10.1093\/rheumatology\/kead461. (Online ahead of print).","DOI":"10.1093\/rheumatology\/kead461"},{"key":"1137_CR89","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41584-023-01065-6","volume":"20","author":"P Ruscitti","year":"2024","unstructured":"Ruscitti P, Cantarini L, Nigrovic PA, McGonagle D, Giacomelli R. Recent advances and evolving concepts in Still\u2019s disease. Nat Rev Rheumatol. 2024;20:116\u201332. https:\/\/doi.org\/10.1038\/s41584-023-01065-6.","journal-title":"Nat Rev Rheumatol"},{"key":"1137_CR90","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.semarthrit.2021.06.004","volume":"51","author":"P Efthimiou","year":"2021","unstructured":"Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still\u2019s disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum. 2021;51:858\u201374. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.06.004.","journal-title":"Semin Arthritis Rheum"},{"key":"1137_CR91","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","volume":"14","author":"P Ruscitti","year":"2016","unstructured":"Ruscitti P, Cipriani P, Masedu F, Iacono D, Ciccia F, Liakouli V, et al. Adult-onset Still\u2019s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers. BMD Med. 2016;14:194. https:\/\/doi.org\/10.1186\/s12916-016-0738-8.","journal-title":"BMD Med."},{"key":"1137_CR92","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.autrev.2016.09.016","volume":"16","author":"P Ruscitti","year":"2017","unstructured":"Ruscitti P, Cipriani P, Ciccia F, Masedu F, Liakouli V, Carubbi F, et al. Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: analysis of 41 cases collected in 2 rheumatologic centers. Autoimmun Rev. 2017;16:16\u201321. https:\/\/doi.org\/10.1016\/j.autrev.2016.09.016.","journal-title":"Autoimmun Rev"},{"key":"1137_CR93","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3899\/jrheum.161286","volume":"44","author":"SS Ahn","year":"2017","unstructured":"Ahn SS, Yoo BW, Jung SM, Lee SW, Park YB, Song JJ. Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still\u2019s disease. J Rheumatol. 2017;44:996\u20131003. https:\/\/doi.org\/10.3899\/jrheum.161286.","journal-title":"J Rheumatol"},{"key":"1137_CR94","doi-asserted-by":"publisher","first-page":"5656320","DOI":"10.1155\/2016\/5656320","volume":"2016","author":"E Watanabe","year":"2016","unstructured":"Watanabe E, Sugawara H, Yamashita T, Ishii A, Oda A, Terai C. Successful tocilizumab therapy for macrophage activation syndrome associated with adult-onset Still\u2019s disease: a case-based review. Case Rep Med. 2016;2016:5656320. https:\/\/doi.org\/10.1155\/2016\/5656320.","journal-title":"Case Rep Med"},{"key":"1137_CR95","first-page":"100","volume":"23","author":"M Amenomori","year":"2005","unstructured":"Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still\u2019s disease. Clin Exp Rheumatol. 2005;23:100\u20132.","journal-title":"Clin Exp Rheumatol"},{"key":"1137_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.819465","volume":"9","author":"L\u00c5 Rolsdorph","year":"2022","unstructured":"Rolsdorph L\u00c5, Mosevoll KA, Helgeland L, Reikvam H. Concomitant hemophagocytic lymphohistiocytosis and cytomegalovirus disease: a case based systemic review. Front Med. 2022;9: 819465. https:\/\/doi.org\/10.3389\/fmed.2022.819465.","journal-title":"Front Med"},{"key":"1137_CR97","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/MAJ.0b013e318159e0b4","volume":"336","author":"Y Tada","year":"2008","unstructured":"Tada Y, Fukuoka M, Mitamura M, Koarada S, Suematsu R, Inoue H, et al. Nocardiosis in adult-onset Still\u2019s disease and vasculitis syndrome. Am J Med Sci. 2008;336:77\u201380. https:\/\/doi.org\/10.1097\/MAJ.0b013e318159e0b4.","journal-title":"Am J Med Sci"},{"key":"1137_CR98","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/art.38398","volume":"66","author":"F Ortiz-Sanju\u00e1n","year":"2014","unstructured":"Ortiz-Sanju\u00e1n F, Blanco R, Calvo-Rio V, Narvaez J, Romero ER, Oliv\u00e9 A, et al. Efficacy of Tocilizumab in conventional treatment-refractory adult-onset Still\u2019s disease. Arthritis Rheum. 2014;66:1659\u201365. https:\/\/doi.org\/10.1002\/art.38398.","journal-title":"Arthritis Rheum"},{"key":"1137_CR99","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh M, Merkel PA, Peh CA, Szpirt WM, Pu\u00e9chal X, Fujimoto S, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382:622\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1803537.","journal-title":"N Engl J Med"},{"key":"1137_CR100","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1001\/jama.2021.6615","volume":"325","author":"S Furuta","year":"2021","unstructured":"Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, et al. Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial. JAMA. 2021;325:2178\u201387. https:\/\/doi.org\/10.1001\/jama.2021.6615.","journal-title":"JAMA"},{"key":"1137_CR101","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10067-024-06905-8","volume":"43","author":"S Suzuki","year":"2024","unstructured":"Suzuki S, Kataoka Y, Otani T, Taniguchi Y, Ikeda K, Tamura N, et al. Optimal time of starting tocilizumab in acute phase of adult-onset Still\u2019s disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature. Clin Rheumatol. 2024;43:1245\u201351. https:\/\/doi.org\/10.1007\/s10067-024-06905-8.","journal-title":"Clin Rheumatol"},{"key":"1137_CR102","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/ard-2023-224123","volume":"82","author":"B Shakoory","year":"2023","unstructured":"Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, et al. The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation sytndrome (HLH\/MAS). Ann Rheum Dis. 2023;82:1271\u201385. https:\/\/doi.org\/10.1136\/ard-2023-224123.","journal-title":"Ann Rheum Dis"},{"key":"1137_CR103","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13075-021-02708-3","volume":"24","author":"T Sugiyama","year":"2020","unstructured":"Sugiyama T, Furuta S, Hiraguri M, Ikeda K, Inaba Y, Kagami S, et al. Latent class analysis of 216 patients with adult-onset Still\u2019s disease. Arthritis Res Ther. 2020;24:7. https:\/\/doi.org\/10.1186\/s13075-021-02708-3.","journal-title":"Arthritis Res Ther"},{"key":"1137_CR104","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003419","volume":"9","author":"P Ruscitti","year":"2023","unstructured":"Ruscitti P, Masedu F, Vitale A, Di Cola I, Caggiano V, Di Muzio C, et al. Derivation and validation of four patient clusters in Still\u2019s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry. RMD Open. 2023;9: e003419. https:\/\/doi.org\/10.1136\/rmdopen-2023-003419.","journal-title":"RMD Open"},{"key":"1137_CR105","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13075-021-02688-4","volume":"23","author":"R Li","year":"2021","unstructured":"Li R, Liu X, Chen G, Tang G, Chen X, Liu X, et al. Clinical phenotypes and prognostic factors of adult-onset Still\u2019s disease: data from a large inpatient cohort. Arthritis Res Ther. 2021;23:300. https:\/\/doi.org\/10.1186\/s13075-021-02688-4.","journal-title":"Arthritis Res Ther"},{"key":"1137_CR106","doi-asserted-by":"publisher","unstructured":"Shirahama Y, Kokuzawa A, Yamauchi Y, Kirino Y, Nagai H, Inoue Y, et al. Cluster analysis defines four groups of Japanese patients with adult-onset Still\u2019s disease. Mod Rheumatol. 2024. https:\/\/doi.org\/10.1093\/mr\/roae023. (Online ahead of print).","DOI":"10.1093\/mr\/roae023"},{"issue":"6 Suppl 115","key":"1137_CR107","first-page":"74","volume":"36","author":"MJ Kim","year":"2018","unstructured":"Kim MJ, Ahn EY, Hwang W, Lee Y, Lee EY, Lee EB, et al. Association between fever pattern and clinical manifestations of adult-onset Still\u2019s disease: unbiased analysis using hierarchical clustering. Clin Exp Rheumatol. 2018;36(6 Suppl 115):74\u20139.","journal-title":"Clin Exp Rheumatol"},{"key":"1137_CR108","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/rheumatology\/keac439","volume":"62","author":"R Guo","year":"2023","unstructured":"Guo R, Liu X, Li Y, Meng X, Li R, Chen X, et al. AOSD endotypes based on immune cell profiles: patient stratification with hierarchical clustering analysis. Rheumatology. 2023;62:1636\u201344. https:\/\/doi.org\/10.1093\/rheumatology\/keac439.","journal-title":"Rheumatology"}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-024-01137-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-024-01137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T16:09:18Z","timestamp":1726762158000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-024-01137-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":108,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1007\/s40266-024-01137-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,3]]},"assertion":[{"value":"16 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research received no specific funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Yoshifumi Tada received speaker\u2019s fees from Chugai.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Planning of the content structure and writing was performed by Yoshifumi Tada. Clinical research and analysis was performed by Akihito Maruyama and Yuri Shirahama.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}